Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0161-6420(00)00663-1PMID 11297487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.

  2000cited by this paper
• The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications.

  1998cited by this paper
• Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

  1998cited by this paper
• Increased expression of angiogenic growth factors in age-related maculopathy

  1997cited by this paper
• Role of vascular permeability factor/vascular endothelial growth factor in eye disease

  1997cited by this paper
• Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.

  1997cited by this paper
• Vascular endothelial growth factor expression in choroidal neovascularization in rats

  1997cited by this paper
• Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

  1996cited by this paper
• Vascular endothelial growth factor and the eye. Past, present and future.

  1996cited by this paper
• Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.

  1996cited by this paper
• Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor.

  1996cited by this paper
• Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study.

  1995cited by this paper
• Fibrinogen and cardiovascular disorders.

  1995cited by this paper
• Preventative ophthalmology. Age-related macular degeneration.

  1995cited by this paper
• The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking.

  1993cited by this paper
• von Willebrand factor and endothelial damage in essential hypertension.

  1993cited by this paper
• Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group.

  1992cited by this paper
• The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus.

  1992cited by this paper
• Risk factor analysis for atrophic and exudative age‐related macular degeneration

  1992cited by this paper
• Practical statistics for medical research

  1990cited by this paper
• Blood rheology in arterial disease.

  1986cited by this paper
• Systemic hypertension and age-related maculopathy in the Framingham Study.

  1986cited by this paper
• Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration.

  1982cited by this paper
• Electron microscopic features of experimental choroidal neovascularization.

  1981cited by this paper
• Gesammelte Abhandlungen zur wissenschaftlichen Medicin

  year unknowncited by this paper

• An association between atrial fibrillation and age-related macular degeneration: looking beyond mere coincidence

  2026cites this paper
• Association between atrial fibrillation and age-related macular degeneration: A nationwide cohort study

  2025cites this paper
• Serum adropin level in wet-type age-related macular degeneration

  2024cites this paper
• Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration

  2024cites this paper
• Potential Retinal Biomarkers in Alzheimer’s Disease

  2023cites this paper
• Alteration of plasma von Willebrand factor in the treatment of retinal vein occlusion with cystoid macular edema

  2022cites this paper
• Therapeutic Plasmapheresis: A Revision of Literature

  2022cites this paper
• Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review

  2022cites this paper
• Walking Exercise Reduces Postprandial Lipemia but Does Not Influence Postprandial Hemorheological Properties and Oxidative Stress

  2022cites this paper
• Single-Cell Transcriptome of Wet AMD Patient-Derived Endothelial Cells in Angiogenic Sprouting

  2022cites this paper
• Effect of a Dexamethasone Implant on Rheological Blood Parameters in Patients Treated for Retinal Vein Thrombosis

  2022cites this paper
• Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration

  2021cites this paper
• Circulating endothelial and progenitor cells in age-related macular degeneration

  2020cites this paper
• Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration

  2020cites this paper
• Idiopathic Choroidal Neovascularization

  2020cites this paper
• Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass

  2020cites this paper
• Deciphering ocular diseases on an epigenetic platform

  2019cites this paper
• Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction

  2019cites this paper
• The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective

  2019cites this paper
• Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration.

  2018cites this paper
• Precision medicine for age-related macular degeneration: current developments and prospects

  2018cites this paper
• Methods of computational modeling of coronary heart vessels for its digital twin

  2018cites this paper
• Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration

  2018cites this paper
• YAP via interacting with STAT3 regulates VEGF‐induced angiogenesis in human retinal microvascular endothelial cells

  2018cites this paper
• A Prospective Investigation of Dietary Intake and Functional Impairments Among the Elderly

  2018cites this paper
• Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage

  2018cites this paper
• Investigation of vascular endothelial dysfunction in the patients with age-related macular degeneration

  2018cites this paper
• INTRAVITREAL DEXAMETHASONE IMPLANT AS ADJUVANT TREATMENT FOR BEVACIZUMAB- AND RANIBIZUMAB-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Prospective Pilot Study

  2017cites this paper
• The association of enzymatic and non-enzymatic antioxidant defense parameters with inflammatory markers in patients with exudative form of age-related macular degeneration

  2017cites this paper
• New neovascular age‐related macular degeneration is associated with systemic leucocyte activity

  2017cites this paper
• Plasma Homocysteine and Asymmetrical Dimethyl-l-Arginine (ADMA) and Whole Blood DNA Methylation in Early and Neovascular Age-Related Macular Degeneration: A Pilot Study*

  2016cites this paper
• Risk factors and biomarkers of age-related macular degeneration.

  2016influential citation
• Serum anti‐endothelial cell antibodies in patients with age‐related macular degeneration treated with intravitreal bevacizumab

  2016influential citation
• Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study

  2016cites this paper
• Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration.

  2016cites this paper
• [The age-related macular degeneration as a vascular disease/part of systemic vasculopathy: contributions to its pathogenesis].

  2015cites this paper
• Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis

  2015cites this paper
• Exploring the role of VEGF in Indian Age related macular degeneration

  2015cites this paper
• Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases.

  2015cites this paper
• Hemorheological parameters and their correlations in OXYS rats: A new model of hyperviscosity syndrome

  2015cites this paper
• Időskori maculadegeneráció mint az érbetegség/szisztémás érbetegség része: adalékok a patogenezishez

  2015cites this paper
• Aberrant cell and basement membrane architecture contribute to sidestream smoke-induced choroidal endothelial dysfunction.

  2014cites this paper
• Patients with early age-related macular degeneration exhibit signs of macro- and micro-vascular disease and abnormal blood glutathione levels

  2014cites this paper
• mAbs Targeting Apoptosis, Angiogenesis Inhibitors, and Other mAbs in Phase 1 and 2 Clinical Studies for Immunological Disorders

  2014cites this paper
• Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.

  2014cites this paper
• Markers of cardiovascular risk in elderly patients with age-related macular degeneration

  2014cites this paper
• Discovery of the connection among age-related macular degeneration, MTHFR C677T and PAI 1 4G/5G gene polymorphisms, and body mass index by means of Bayesian inference methods

  2013cites this paper
• A man with age-related macular degeneration and pulmonary thromboembolism

  2013cites this paper
• Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.

  2013cites this paper
• AMD: Epidemiology and Risk Factors

  2013cites this paper
• Endothelial Progenitor Cells and Plasma Vascular Endothelial Growth Factor and Stromal Cell-Derived Factor-1 During Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration

  2013cites this paper
• Association between diet quality with concurrent vision and hearing impairment in older adults

  2013cites this paper
• LUCEDEX: A Prospective Study Comparing Ranibizumab plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Neovascular Age-Related Macular Degeneration

  2013cites this paper
• Complement system activation and endothelial dysfunction in patients with age‐related macular degeneration (AMD): possible relationship between AMD and atherosclerosis

  2012cites this paper
• Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD.

  2012cites this paper
• Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

  2012cites this paper
• Choroidal Neovascular Membrane in Age-Related Macular Degeneration is Associated with Increased Interleukin-6

  2012cites this paper
• Vascular endothelial growth factors in retinal and choroidal neovascular diseases

  2012cites this paper
• Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population

  2012cites this paper
• Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks

  2012cites this paper
• Different populations of circulating endothelial cells in patients with the exudative form of age-related macular degeneration: a novel insight into pathogenesis

  2011cites this paper
• Serum VEGF and CFH in Exudative Age-Related Macular Degeneration

  2011cites this paper
• Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration

  2011cites this paper
• Different populations of circulating endothelial cells in patients with age-related macular degeneration: a novel insight into pathogenesis.

  2011cites this paper
• Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration.

  2011cites this paper
• Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema—a mechanism for regulating angiogenesis?

  2011cites this paper
• Macular pigment optical density is related to blood glutathione levels in healthy individuals.

  2011cites this paper
• Yaşa Bağli Makula Dejenerasyonuna Sekonder Gelişen Koroid Neovaskülarizasyonunun Tedavisinde Kullanilan İntravitreal anti-Vasküler Endotelyal Büyüme Faktörü Ajanlarinin Etkinliğini Değerlendirmede Kompleman Faktör H Polimorfiziminin Yeri

  2011cites this paper
• Genetics of Age-Related Macular Degeneration

  2011cites this paper
• Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD.

  2011cites this paper
• Serum Inflammatory Factors in Patients with Idiopathic Choroidal Neovascularization

  2010cites this paper
• Molecular interactions in cancer cell metastasis.

  2010cites this paper
• Bevacizumab for the treatment of pediatric retinal and choroidal diseases.

  2010cites this paper
• Effects of antioxidants (AREDS medication) on ocular blood flow and endothelial function in an endotoxin-induced model of oxidative stress in humans.

  2010cites this paper
• Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case–control study

  2010cites this paper
• Vascular Endothelial Growth Factors In Eye Diseases Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis

  2009cites this paper
• Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.

  2009cites this paper
• Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice.

  2009cites this paper
• [A new possible strategy for prevention and preventive treatment of age-related macular degeneration resting on recent clinical and pathophysiological observations].

  2009cites this paper
• Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

  2009cites this paper
• Psychoneuroimmunology: application to ocular diseases

  2009cites this paper
• [Application of aptamers to medicine: pharmacological profile and results of clinical trials on pegaptanib sodium (Macugen) for age-related macular degeneration].

  2009cites this paper
• アプタマーの医薬品への応用：加齢黄斑変性治療薬ペガプタニブナトリウム（マクジェン®）の薬理学的特徴と臨床成績

  2009cites this paper
• Nouveaux traitements de la dégénérescence maculaire liée à l'âge

  2009cites this paper
• A Possible Strategy for the Prevention and Preventive Therapy of Age-Related Macular Degeneration Based on Recent Pathophysiological and Clinical Observations*

  2009cites this paper
• Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency.

  2009cites this paper
• Acute and Subacute Effect of Rheopheresis on Microvascular Endothelial Function in Patients Suffering From Age‐related Macular Degeneration

  2009cites this paper
• Pigment epithelium-derived factor gene Met72Thr polymorphism is associated with increased risk of wet age-related macular degeneration.

  2008cites this paper
• Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration.

  2008cites this paper
• [New possibilities in the pharmacologic prevention of age-related macular degeneration].

  2008cites this paper
• Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.

  2008cites this paper
• Correlations in some pathogenetic factors and values of hemorheological parameters in age-related macular degeneration

  2008cites this paper
• Racial differences and other risk factors for incidence and progression of age-related macular degeneration: Salisbury Eye Evaluation (SEE) Project.

  2008cites this paper
• Retinal vascular caliber and age-related macular degeneration: the Singapore Malay Eye Study.

  2008cites this paper
• Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration.

  2008cites this paper
• Age-Related Maculopathy and Diabetes

  2008cites this paper
• Clinicopathologic correlation of retinal angiomatous proliferation.

  2008cites this paper
• [Oxidative stress in association with risk factors for the occurrence and development of age-related macular degeneration].

  2008cites this paper
• A new possible strategy of prevention and preventive treatment of age-related macular degeneration

  2008cites this paper
• Evaluation of Homocysteine and Plasminogen Activator Inhibitor-1 Changes in Age Related Macular Degeneration

  2008cites this paper